Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds

An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a...

from NDTV News - Topstories https://ift.tt/3i0O2FL
https://ift.tt/eA8V8J